Epigenetics of Colorectal Cancer
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cytogenetics, Chromosomal Genetics
Cytogenetics Chromosomal Genetics Sophie Dahoun Service de Génétique Médicale, HUG Geneva, Switzerland [email protected] Training Course in Sexual and Reproductive Health Research Geneva 2011 Cytogenetics is the branch of genetics that correlates the structure, number, and behaviour of chromosomes with heredity and diseases Conventional cytogenetics Molecular cytogenetics Molecular Biology I. Karyotype Definition Chromosomal Banding Resolution limits Nomenclature The metaphasic chromosome telomeres p arm q arm G-banded Human Karyotype Tjio & Levan 1956 Karyotype: The characterization of the chromosomal complement of an individual's cell, including number, form, and size of the chromosomes. A photomicrograph of chromosomes arranged according to a standard classification. A chromosome banding pattern is comprised of alternating light and dark stripes, or bands, that appear along its length after being stained with a dye. A unique banding pattern is used to identify each chromosome Chromosome banding techniques and staining Giemsa has become the most commonly used stain in cytogenetic analysis. Most G-banding techniques require pretreating the chromosomes with a proteolytic enzyme such as trypsin. G- banding preferentially stains the regions of DNA that are rich in adenine and thymine. R-banding involves pretreating cells with a hot salt solution that denatures DNA that is rich in adenine and thymine. The chromosomes are then stained with Giemsa. C-banding stains areas of heterochromatin, which are tightly packed and contain -
GENETICS and GENOMICS Ed
GENETICS AND GENOMICS Ed. Csaba Szalai, PhD GENETICS AND GENOMICS Editor: Csaba Szalai, PhD, university professor Authors: Chapter 1: Valéria László Chapter 2, 3, 4, 6, 7: Sára Tóth Chapter 5: Erna Pap Chapter 8, 9, 10, 11, 12, 13, 14: Csaba Szalai Chapter 15: András Falus and Ferenc Oberfrank Keywords: Mitosis, meiosis, mutations, cytogenetics, epigenetics, Mendelian inheritance, genetics of sex, developmental genetics, stem cell biology, oncogenetics, immunogenetics, human genomics, genomics of complex diseases, genomic methods, population genetics, evolution genetics, pharmacogenomics, nutrigenetics, gene environmental interaction, systems biology, bioethics. Summary The book contains the substance of the lectures and partly of the practices of the subject of ‘Genetics and Genomics’ held in Semmelweis University for medical, pharmacological and dental students. The book does not contain basic genetics and molecular biology, but rather topics from human genetics mainly from medical point of views. Some of the 15 chapters deal with medical genetics, but the chapters also introduce to the basic knowledge of cell division, cytogenetics, epigenetics, developmental genetics, stem cell biology, oncogenetics, immunogenetics, population genetics, evolution genetics, nutrigenetics, and to a relative new subject, the human genomics and its applications for the study of the genomic background of complex diseases, pharmacogenomics and for the investigation of the genome environmental interactions. As genomics belongs to sytems biology, a chapter introduces to basic terms of systems biology, and concentrating on diseases, some examples of the application and utilization of this scientific field are also be shown. The modern human genetics can also be associated with several ethical, social and legal issues. The last chapter of this book deals with these issues. -
Epigenetics in Clinical Practice: the Examples of Azacitidine and Decitabine in Myelodysplasia and Acute Myeloid Leukemia
Leukemia (2013) 27, 1803–1812 & 2013 Macmillan Publishers Limited All rights reserved 0887-6924/13 www.nature.com/leu SPOTLIGHT REVIEW Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia EH Estey Randomized trials have clearly demonstrated that the hypomethylating agents azacitidine and decitabine are more effective than ‘best supportive care’(BSC) in reducing transfusion frequency in ‘low-risk’ myelodysplasia (MDS) and in prolonging survival compared with BSC or low-dose ara-C in ‘high-risk’ MDS or acute myeloid leukemia (AML) with 21–30% blasts. They also appear equivalent to conventional induction chemotherapy in AML with 420% blasts and as conditioning regimens before allogeneic transplant (hematopoietic cell transplant, HCT) in MDS. Although azacitidine or decitabine are thus the standard to which newer therapies should be compared, here we discuss whether the improvement they afford in overall survival is sufficient to warrant a designation as a standard in treating individual patients. We also discuss pre- and post-treatment covariates, including assays of methylation to predict response, different schedules of administration, combinations with other active agents and use in settings other than active disease, in particular post HCT. We note that rational development of this class of drugs awaits delineation of how much of their undoubted effect in fact results from hypomethylation and reactivation of gene expression. Leukemia (2013) 27, 1803–1812; doi:10.1038/leu.2013.173 -
Cytogenetic Mapping and Contribution to the Knowledge of Animal Genomes
In: Advances in Genetics Research. Volume 4 ( in press ) ISBN 978-1-61728-764-0 Editor: Kevin V. Urbano, pp. © 2010 Nova Science Publishers, Inc. Chapter 1 Cytogenetic Mapping and Contribution to the Knowledge of Animal Genomes Cesar Martins, Diogo Cavalcanti Cabral-de-Mello, Guilherme Targino Valente, Juliana Mazzuchelli and Sarah Gomes de Oliveira UNESP – Univ Estadual Paulista, Departamento de Morfologia, Instituto de Biociências, Botucatu, SP, Brazil. Abstract Decades before the recent advances in molecular biology and the knowledge of the complete nucleotide sequence of several genomes, cytogenetic analysis provided the first information concerning the genome organization. Since the beginning of cytogenetics, great effort has been applied for understanding the chromosome evolution in a wide range of taxonomic groups. The exploration of molecular biology techniques in the cytogenetic area represents a powerful tool for advancement in the construction of physical chromosome maps of the genomes. The most important contribution of cytogenetics is related to the physical anchorage of genetic linkage maps in the chromosomes through the hybridization of DNA markers onto chromosomes. Several technologies, such as polymerase chain reaction (PCR), enzymatic restriction, flow sorting, chromosome microdissection and BAC library construction, associated with distinct labeling methods and fluorescent detection systems have allowed for the generation of a range of useful DNA probes applied in chromosome physical mapping. Concerning the probes used for molecular cytogenetics, the repetitive DNA is amongst the most explored nucleotide sequences. The recent development of bacterial artificial chromosomes (BACs) as vectors for carrying large genome fragments has allowed for the utilization of BACs as probes for the purpose of chromosome mapping. -
Molecular Biology and Applied Genetics
MOLECULAR BIOLOGY AND APPLIED GENETICS FOR Medical Laboratory Technology Students Upgraded Lecture Note Series Mohammed Awole Adem Jimma University MOLECULAR BIOLOGY AND APPLIED GENETICS For Medical Laboratory Technician Students Lecture Note Series Mohammed Awole Adem Upgraded - 2006 In collaboration with The Carter Center (EPHTI) and The Federal Democratic Republic of Ethiopia Ministry of Education and Ministry of Health Jimma University PREFACE The problem faced today in the learning and teaching of Applied Genetics and Molecular Biology for laboratory technologists in universities, colleges andhealth institutions primarily from the unavailability of textbooks that focus on the needs of Ethiopian students. This lecture note has been prepared with the primary aim of alleviating the problems encountered in the teaching of Medical Applied Genetics and Molecular Biology course and in minimizing discrepancies prevailing among the different teaching and training health institutions. It can also be used in teaching any introductory course on medical Applied Genetics and Molecular Biology and as a reference material. This lecture note is specifically designed for medical laboratory technologists, and includes only those areas of molecular cell biology and Applied Genetics relevant to degree-level understanding of modern laboratory technology. Since genetics is prerequisite course to molecular biology, the lecture note starts with Genetics i followed by Molecular Biology. It provides students with molecular background to enable them to understand and critically analyze recent advances in laboratory sciences. Finally, it contains a glossary, which summarizes important terminologies used in the text. Each chapter begins by specific learning objectives and at the end of each chapter review questions are also included. -
Cytogenetics, Chromosomal Genetics
Cytogenetics Chromosomal Genetics Sophie Dahoun Service de Génétique Médicale, HUG Geneva, Switzerland [email protected] Training Course in Sexual and Reproductive Health Research Geneva 2010 Cytogenetics is the branch of genetics that correlates the structure, number, and behaviour of chromosomes with heredity and diseases Conventional cytogenetics Molecular cytogenetics Molecular Biology I. Karyotype Definition Chromosomal Banding Resolution limits Nomenclature The metaphasic chromosome telomeres p arm q arm G-banded Human Karyotype Tjio & Levan 1956 Karyotype: The characterization of the chromosomal complement of an individual's cell, including number, form, and size of the chromosomes. A photomicrograph of chromosomes arranged according to a standard classification. A chromosome banding pattern is comprised of alternating light and dark stripes, or bands, that appear along its length after being stained with a dye. A unique banding pattern is used to identify each chromosome Chromosome banding techniques and staining Giemsa has become the most commonly used stain in cytogenetic analysis. Most G-banding techniques require pretreating the chromosomes with a proteolytic enzyme such as trypsin. G- banding preferentially stains the regions of DNA that are rich in adenine and thymine. R-banding involves pretreating cells with a hot salt solution that denatures DNA that is rich in adenine and thymine. The chromosomes are then stained with Giemsa. C-banding stains areas of heterochromatin, which are tightly packed and contain -
Interplay Between P53 and Epigenetic Pathways in Cancer
University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2016 Interplay Between P53 and Epigenetic Pathways in Cancer Jiajun Zhu University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Biology Commons, Cell Biology Commons, and the Molecular Biology Commons Recommended Citation Zhu, Jiajun, "Interplay Between P53 and Epigenetic Pathways in Cancer" (2016). Publicly Accessible Penn Dissertations. 2130. https://repository.upenn.edu/edissertations/2130 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2130 For more information, please contact [email protected]. Interplay Between P53 and Epigenetic Pathways in Cancer Abstract The human TP53 gene encodes the most potent tumor suppressor protein p53. More than half of all human cancers contain mutations in the TP53 gene, while the majority of the remaining cases involve other mechanisms to inactivate wild-type p53 function. In the first part of my dissertation research, I have explored the mechanism of suppressed wild-type p53 activity in teratocarcinoma. In the teratocarcinoma cell line NTera2, we show that wild-type p53 is mono-methylated at Lysine 370 and Lysine 382. These post-translational modifications contribute ot the compromised tumor suppressive activity of p53 despite a high level of wild-type protein in NTera2 cells. This study provides evidence for an epigenetic mechanism that cancer cells can exploit to inactivate p53 wild-type function. The paradigm provides insight into understanding the modes of p53 regulation, and can likely be applied to other cancer types with wild-type p53 proteins. On the other hand, cancers with TP53 mutations are mostly found to contain missense substitutions of the TP53 gene, resulting in expression of full length, but mutant forms of p53 that confer tumor-promoting “gain-of-function” (GOF) to cancer. -
Genomic and Epigenomic EBF1 Alterations Modulate TERT Expression in Gastric Cancer
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer Manjie Xing, … , Bin Tean Teh, Patrick Tan J Clin Invest. 2020;130(6):3005-3020. https://doi.org/10.1172/JCI126726. Research Article Gastroenterology Oncology Graphical abstract Find the latest version: https://jci.me/126726/pdf The Journal of Clinical Investigation RESEARCH ARTICLE Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer Manjie Xing,1,2,3 Wen Fong Ooi,2 Jing Tan,4,5 Aditi Qamra,2,3 Po-Hsien Lee,6 Zhimei Li,5 Chang Xu,1,6 Nisha Padmanabhan,1 Jing Quan Lim,7 Yu Amanda Guo,8 Xiaosai Yao,9 Mandoli Amit,1 Ley Moy Ng,6 Taotao Sheng,1,10 Jing Wang,1 Kie Kyon Huang,1 Chukwuemeka George Anene-Nzelu,11,12 Shamaine Wei Ting Ho,1,6 Mohana Ray,13 Lijia Ma,13 Gregorio Fazzi,14 Kevin Junliang Lim,1 Giovani Claresta Wijaya,5 Shenli Zhang,1 Tannistha Nandi,2 Tingdong Yan,1 Mei Mei Chang,8 Kakoli Das,1 Zul Fazreen Adam Isa,2 Jeanie Wu,1 Polly Suk Yean Poon,2 Yue Ning Lam,2 Joyce Suling Lin,2 Su Ting Tay,1 Ming Hui Lee,1 Angie Lay Keng Tan,1 Xuewen Ong,1 Kevin White,13,15 Steven George Rozen,1,16 Michael Beer,17,18 Roger Sik Yin Foo,11,12 Heike Irmgard Grabsch,14,19 Anders Jacobsen Skanderup,8 Shang Li,1,20 Bin Tean Teh,1,5,6,9,16,20 and Patrick Tan1,2,6,16,21,22,23 1Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore. -
Cytogenetics Can It Make Sense?
Reporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota Reporting cytogenetics • What is it? • Terminology • Clinical value • What details are important Diagnostic Tools for Leukemia • Microscope What do the cells (blasts) look like? How do they stain? • Flow Cytometry fluorescent antibody measure of molecules and density on cells • Cytogenetics Chromosome number, structure and changes • Molecular testing (PCR) DNA or RNA changes that indicate the tumor cells Diagnosis- Immunocytochemistry MPO and PAS (red) in normal MPO in M2 (orange) BM M7 Factor VIII related protein identifies blasts of megakaryocyte lineage. Immunocytochemistry M5 M5 Strongly positive for the Chloroacetate esterase stains nonspecific esterase Inhibited by neutrophils blue,nonspecific Fluoride. esterase stains monocytes red- brown Reporting cytogenetics • How are they tested? • What is FISH? • What’s the difference? • What do they mean? Reporting cytogenetics • How are they tested? Structural and numerical changes in chromosomes—while cells are dividing • What is FISH? Fluorescent in situ hybridization Specific markers on defined chromosome sites • What’s the difference? Dividing (metaphase) vs non-dividing (interphase) • What do they mean? Molecular probes to find chromsome changes Specimen requirements • Cytogenetics – Sodium heparin (green top) – Core biopsy acceptable (in saline, RPMI or other media) – FFPE tissue acceptable for FISH UNLESS it has been decalcified • G-banding – Requires dividing cells to be able to examine chromosomes -
Epigenetics Changes in Breast Cancer
ering & B ne io gi m n e e d io i c B a f l Behera P, J Bioengineer & Biomedical Sci 2017, S Journal of o l c a i e n n r 7:2 c u e o J DOI: 10.4172/2155-9538.1000223 ISSN: 2155-9538 Bioengineering & Biomedical Science Review Article Open Access Epigenetics Changes in Breast Cancer: Current Aspects in India Behera P* Department of Biotechnology, Amity University, Lucknow, India *Corresponding author: Behera P, Department of Biotechnology, Amity University, Lucknow, India, Tel: 9703466651; E-mail: [email protected] Received date: March 25, 2017; Accepted date: April 4, 2017; Published date: April 15, 2017 Copyright: © 2017 Behera P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. Abstract Epigenetics is turning out to be one of the promising studies in cancer research. This review focuses mainly on how genetic and epigenetic factors like DNA methylation, histone modifications and various other genes can assess the promoter region of cancer related genes and provides a tool for cancer diagnosis and research. The objective of the review is to provide an overview of the literature with some recent developments providing insights into the important question of co-evolution of epigenetic changes in breast cancer progression and tumorigenesis. This review also comply study of different genetic changes existing in breast cancer. Further in this review focus on functioning of DNA methylation, including both normal, disruptions or abnormal role in human disease, and changes in DNA methylation during human breast cancer is also noted. -
The Role of Cytogenetics and Molecular Biology in the Diagnosis
REVIEW ARTICLE J Bras Patol Med Lab. 2018 Apr; 54(2): 83-91. The role of cytogenetics and molecular biology in the diagnosis, treatment and monitoring of patients with chronic myeloid leukemia 10.5935/1676-2444.20180015 O papel da citogenética e da biologia molecular no diagnóstico, no tratamento e no monitoramento de pacientes com leucemia mieloide crônica Luiza Emy Dorfman1; Maiara A. Floriani1; Tyana Mara R. D. R. Oliveira1; Bibiana Cunegatto1; Rafael Fabiano M. Rosa1, 2; Paulo Ricardo G. Zen1, 2 1. Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rio Grande do Sul, Brazil. 2. Complexo Hospitalar Santa Casa de Porto Alegre (CHSCPA), Rio Grande do Sul, Brazil. ABSTRACT Chronic myeloid leukemia (CML) is the most common myeloproliferative disorder among chronic neoplasms. The history of this disease joins with the development of cytogenetic analysis techniques in human. CML was the first cancer to be associated with a recurrent chromosomal alteration, a reciprocal translocation between the long arms of chromosomes 9 and 22 – Philadelphia chromosome. This work is an updated review on CML, which highlights the importance of cytogenetics analysis in the continuous monitoring and therapeutic orientation of this disease. The search for scientific articles was carried out in the PubMed electronic database, using the descriptors “leukemia”, “chronic myeloid leukemia”, “treatment”, “diagnosis”, “karyotype” and “cytogenetics”. Specialized books and websites were also included. Detailed cytogenetic and molecular monitoring can assist in choosing the most effective drug for each patient, optimizing the treatment. Cytogenetics plays a key role in the detection of chromosomal abnormalities associated with malignancies, as well as the characterization of new alterations that allow more research and increase knowledge about the genetic aspects of these diseases. -
Epigenetic Inactivation of the P53-Induced Long Noncoding RNA
Epigenetic inactivation of the p53-induced long PNAS PLUS noncoding RNA TP53 target 1 in human cancer Angel Diaz-Lagaresa, Ana B. Crujeirasa,b,c, Paula Lopez-Serraa, Marta Solera, Fernando Setiena, Ashish Goyald,e, Juan Sandovala, Yutaka Hashimotoa, Anna Martinez-Cardúsa, Antonio Gomeza, Holger Heyna, Catia Moutinhoa, Jesús Espadaf,g, August Vidalh, Maria Paúlesh, Maica Galáni, Núria Salaj, Yoshimitsu Akiyamak, María Martínez-Iniestal, Lourdes Farrél,m, Alberto Villanueval, Matthias Grossd,e, Sven Diederichsd,e,n,o,p, Sonia Guila,1, and Manel Estellera,q,r,1 aCancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, 08908 Barcelona, Catalonia, Spain; bCentro de Investigación Biomédica en Red (CIBER) Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto Salud Carlos III, 28029 Madrid, Spain; cEndocrine Division, Complejo Hospitalario Universitario de Santiago, 15706 Santiago de Compostela, Spain; dDivision of RNA Biology and Cancer (B150), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; eInstitute of Pathology, University Hospital Heidelberg, 69120 Heidelberg, Germany; fExperimental Dermatology and Skin Biology Group, Ramón y Cajal Institute for Biomedical Research (IRYCIS), Ramón y Cajal University Hospital, 28034 Madrid, Spain; gBionanotechnology Laboratory, Bernardo O’Higgins University, Santiago 8370854, Chile; hPathology Department, Hospital Universitari de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, 08907 Barcelona, Catalonia, Spain;